New York Life Investment Management LLC Raises Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

New York Life Investment Management LLC boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,837 shares of the company’s stock after buying an additional 377 shares during the period. New York Life Investment Management LLC’s holdings in Henry Schein were worth $2,638,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. Victory Capital Management Inc. increased its stake in Henry Schein by 10.9% during the fourth quarter. Victory Capital Management Inc. now owns 151,657 shares of the company’s stock worth $11,482,000 after acquiring an additional 14,868 shares during the last quarter. Savant Capital LLC purchased a new position in Henry Schein during the fourth quarter worth $264,000. Van ECK Associates Corp increased its position in Henry Schein by 2.8% during the fourth quarter. Van ECK Associates Corp now owns 17,352 shares of the company’s stock valued at $1,314,000 after acquiring an additional 472 shares during the last quarter. Russell Investments Group Ltd. raised its stake in shares of Henry Schein by 45.6% in the fourth quarter. Russell Investments Group Ltd. now owns 345,731 shares of the company’s stock valued at $26,180,000 after acquiring an additional 108,258 shares during the period. Finally, Headlands Technologies LLC bought a new stake in shares of Henry Schein in the 4th quarter worth about $193,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Trading Down 1.2 %

HSIC opened at $67.78 on Monday. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The firm has a market cap of $8.71 billion, a price-to-earnings ratio of 21.52, a PEG ratio of 1.68 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The stock has a fifty day moving average price of $73.46 and a 200-day moving average price of $72.32.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The firm had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the prior year, the firm posted $1.21 earnings per share. The business’s revenue for the quarter was down 10.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Barrington Research raised their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 28th. Piper Sandler lifted their target price on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. Evercore ISI boosted their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research report on Wednesday, February 28th. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.